Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early daily constipation treatment to prevent wound infection in burn inpatients
IRCT20201226049834N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of bisacodyl and lactulose in constipation (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Evaluation of constipation status, Wound infection and 2 more. Started May 2021; status: completed.
02
Drugs
bisacodyllactulose
03
Conditions
constipation
Beyond the preview
Go deeper on IRCT20201226049834N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201226049834N1.